Grade: C — Some Red Flags, Investigate
Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles
Data: SEC EDGAR 10-K (Filed 2026-02-06, FY ended December 31, 2025) + Yahoo Finance
Auditor: KPMG LLP — Unqualified opinion
**Note on REIT grading**: Healthcare REITs carry higher leverage than average due to the capital-intensive nature of senior housing operations. Grade adjusted for REIT context but leverage remains a genuine concern.
One-line verdict: Ventas is a healthcare REIT in recovery mode. Revenue surged 18.5% to $5.83 billion and net income improved to $251 million from $81 million in FY2024 (after a net loss in FY2023), driven by strong senior housing operating portfolio (SHOP) performance. Nareit FFO attributable to common stockholders rose 24.0% to $1.62 billion and Normalized FFO rose 21.3% to $1.61 billion. However, the balance sheet carries significant stress: Debt/EBITDA is 5.8x, interest coverage is only 1.4x, and $13.2 billion in debt sits against $741 million in cash. The Beneish M-Score could not be computed due to insufficient data. The recovery trajectory is real, but the leverage profile demands monitoring.
| Metric | Result |
|---|---|
| Red Flags | **1** (Leverage: Debt/EBITDA 5.8x, interest coverage 1.4x) |
| Watch Items | **0** |
| Checks Completed | **16/18** (2 N/A: impairment, M-Score) |
| Beneish M-Score | **N/A** (insufficient data) |
| Auditor | KPMG LLP — Unqualified opinion |
Healthcare REIT: The Recovery Story
Ventas owns a diversified portfolio of healthcare properties including senior housing, medical office buildings, life science properties, and healthcare facilities. The company was severely impacted by COVID-19 disruptions to senior housing occupancy and has been on a multi-year recovery path.
The filing reports revenue composition across three major segments: Senior Housing Operating Portfolio (SHOP), Outpatient Medical and Research Portfolio, and Triple-Net Leased Properties.
FFO: Strong Recovery
| Metric | FY2023 | FY2024 | FY2025 | Trend |
|---|---|---|---|---|
| Revenue | $4,498M | $4,924M | $5,834M | +18.5% YoY |
| Net Income (Loss) | ($41M) | $81M | $251M | Turnaround |
| EPS (diluted) | ($0.10) | $0.19 | $0.54 | Recovery |
| Nareit FFO | $1,322M | $1,305M | $1,619M | +24.0% YoY |
| Normalized FFO | $1,212M | $1,327M | $1,610M | +21.3% YoY |
| Nareit FFO per diluted share | ~$3.21 | ~$2.82 | ~$3.54 | +25.5% |
Per the filing, "Net income (loss) attributable to common stockholders" improved from a $41 million loss in FY2023 to $251 million income in FY2025. Nareit FFO of $1.619 billion adds back $1.373 billion in real estate depreciation, $78 million in unconsolidated entity depreciation, and $39 million in disposition gains.
Normalized FFO of $1.610 billion makes additional adjustments for derivatives, non-cash tax impacts, debt extinguishment, transaction costs, and changes to executive equity compensation. Per the filing, FY2025 Normalized FFO includes a $14.2 million favorable adjustment "primarily related to the net non-cash revenue impact of changed revenue recognition from cash to straight-line related to a Senior Housing Triple-Net tenant."
Cash Flow
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating Cash Flow | $1,120M | $1,330M | $1,647M |
| Net Income (Loss) | ($41M) | $81M | $251M |
| CFFO / Net Income | N/M | 16.4x | 6.6x |
| CapEx | $643M | $604M | $645M |
| Free Cash Flow | $477M | $726M | $1,002M |
| Accruals Ratio | — | — | -5.1% |
Operating cash flow grew 23.8% to $1.65 billion — a significant improvement reflecting the SHOP recovery. The high CFFO/NI ratio (6.6x) is expected for a healthcare REIT where depreciation ($1.37 billion) far exceeds net income ($251 million). The accruals ratio of -5.1% is clean. Free cash flow of $1.0 billion more than doubled from FY2023's $477 million.
The 18-Point Screening
Revenue Quality
| # | Check | Result | Detail |
|---|---|---|---|
| A1 | DSO Change | Pass | DSO 16 days, +1 day — excellent |
| A2 | AR vs Revenue Growth | Pass | AR +23.8% vs revenue +18.5% (proportionate) |
| A3 | Revenue vs CFFO | Pass | Revenue +18.5%, CFFO +23.8% (cash outpacing) |
Revenue quality is strong: DSO is very low at 16 days, and operating cash flow is growing faster than revenue — a positive signal.
Expense Quality
| # | Check | Result | Detail |
|---|---|---|---|
| B1 | Inventory vs COGS | Pass | No material inventory |
| B2 | CapEx vs Revenue | Pass | CapEx +6.8% vs revenue +18.5% |
| B3 | SG&A Ratio | Pass | SG&A/Gross Profit = 7.3%, excellent |
| B4 | Gross Margin | Pass | 41.4%, -1.2pp — stable |
Gross margin declined slightly from 42.6% to 41.4%, reflecting the SHOP segment's higher operating cost structure as Ventas takes on more direct senior housing operations.
Cash Flow Quality
| # | Check | Result | Detail |
|---|---|---|---|
| C1 | CFFO vs Net Income | Pass | CFFO/NI = 6.55x |
| C2 | Free Cash Flow | Pass | FCF $1.0B, FCF/NI = 3.99x |
| C3 | Accruals Ratio | Pass | -5.1%, low accruals |
| C4 | Cash vs Debt | **REIT Context** | Cash $741M vs debt $13.2B — high but typical for healthcare REIT |
Balance Sheet
| # | Check | Result | Detail |
|---|---|---|---|
| D1 | Goodwill + Intangibles | Pass | $1.06B goodwill = 8% of equity |
| D2 | Leverage | Fail | Debt/EBITDA = 5.8x, interest coverage = 1.4x |
| D3 | Soft Asset Growth | Pass | Other assets -24.1% vs revenue +18.5% |
| D4 | Asset Impairment | — | No write-off data |
D2 is the red flag. Debt/EBITDA of 5.8x is elevated even for a healthcare REIT. Interest coverage of only 1.4x means Ventas's operating income barely covers its interest expense. Per the filing, the weighted average effective interest rate was 4.56% for 2025, up from 4.41% in 2024, adding $20.1 million in interest expense. Total consolidated debt includes $328.2 million from joint venture partners' share.
Acquisition Risk
| # | Check | Result | Detail |
|---|---|---|---|
| E1 | Serial Acquirer FCF | Pass | FCF after acquisitions positive |
| E2 | Goodwill Surge | Pass | Goodwill +0% YoY |
Manipulation Score
| # | Check | Result | Detail |
|---|---|---|---|
| F1 | Beneish M-Score | — | Insufficient data |
Key Risks from the 10-K
1. Interest Coverage of 1.4x — Dangerously Low
Interest coverage of 1.4x leaves Ventas with almost no margin for operational disruption. A single bad quarter in the SHOP segment could push interest coverage below 1.0x. The filing discloses that the company's "financial covenant ratios under credit facilities and senior notes indentures" are tied to interest coverage metrics. Any breach would trigger restrictive covenants or acceleration clauses.
2. Senior Housing Operating Risk
Unlike triple-net REITs that collect contractual rent, Ventas directly operates many senior housing properties through its SHOP segment. This exposes the company to: (1) labor costs and staffing shortages, (2) occupancy risk from demographic shifts, (3) regulatory changes in senior care, and (4) pandemic-related disruptions. The revenue growth is real, but so are the operating risks.
3. Goodwill of $1.05 Billion
Ventas carries $1.046 billion in goodwill, primarily from past acquisitions. While this is only 8% of equity, any sustained decline in property values or operating performance could trigger impairment testing and write-downs that would reduce equity and worsen leverage ratios.
4. Revenue Recognition Changes
The filing discloses that FY2025 Normalized FFO adjustments include "the net non-cash revenue impact of changed revenue recognition from cash to straight-line related to a Senior Housing Triple-Net tenant." Changes in revenue recognition methodology can signal underlying tenant credit issues — moving from cash to straight-line recognition may mean the tenant's cash payments no longer support GAAP revenue timing.
5. Debt Maturity Wall
With $13.2 billion in debt and an interest rate environment that has elevated borrowing costs, Ventas faces refinancing risk on maturing debt. The filing discloses $20.1 million in additional interest expense from rate increases in FY2025 alone.
Summary
Grade: C. Strong operating recovery, but leverage is genuinely concerning.
Ventas is executing a compelling recovery in its senior housing portfolio. Revenue grew 18.5%, Nareit FFO grew 24.0%, and operating cash flow surged 23.8%. The accruals ratio is clean, DSO is low, and cash flow quality is strong. The goodwill balance is manageable at 8% of equity.
However, the leverage profile is not manageable for a company with direct operating risk: Debt/EBITDA of 5.8x and interest coverage of 1.4x would be concerning for any REIT, and they are particularly worrying for one that directly operates senior housing facilities rather than collecting contractual triple-net rent. A single operational disruption — a recession reducing occupancy, a staffing crisis, or a regulatory change — could stress the balance sheet beyond its current limits.
The trajectory is positive, but the margin of safety is thin.
**Disclaimer**: This report is based on Ventas's FY2025 10-K filed with SEC EDGAR on February 6, 2026. This is NOT investment advice.
Data: SEC EDGAR 10-K + Yahoo Finance
Auditor: KPMG LLP (Unqualified opinion)
Fiscal year ended: December 31, 2025